Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BTK inhibitors
Biotech
Sanofi BTK inhibitor for blood disease raises platelet levels
Patients receiving the drug also saw meaningful improvements in physical fatigue and bleeding compared to the placebo group.
Darren Incorvaia
Nov 5, 2024 1:42pm
Sanofi lifts lid on data behind tolebrutinib’s mixed MS studies
Sep 20, 2024 7:07am
Sanofi's tolebrutinib fails 2 of 3 late-stage MS trials
Sep 2, 2024 1:00am
Sanofi nails phase 3 LUNA landing, sparking race to regulators
Apr 23, 2024 2:23am
Novartis lines up another potential indication for BTK inhibitor
Mar 9, 2024 12:00pm
Merck KGaA drops evobrutinib in wake of double phase 3 fail
Mar 7, 2024 9:54am